Beginning with a debate on clopidogrel monotherapy after DAPT, this issue of EuroIntervention offers a viewpoint on invasive strategy timing in non-ST-elevation-acute coronary syndromes (NSTE-ACS); original research on intracoronary cooling to reduce infarct size from the EURO-ICE trial; a three-year comparison of polymer technology in acute coronary syndromes from the HOST REDUCE POLYTECH RCT Trial; leaflet splitting for coronary access after redo-TAVI; the use of fibrosis patterns as a prognostic tool post-TAVI; a research correspondence on the midterm durability of ACURATE neo TAVI; a look at the novel 3DStent to evaluate stent expansion; news from the EAPCI; and more...
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)